BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Hepatol. Jul 27, 2026; 18(7): 122926
Published online Jul 27, 2026. doi: 10.4254/wjh.122926
Figure 1
Figure 1 Kaplan-Meier failure curve for cumulative chronic kidney disease probability of metabolic dysfunction-associated steatotic liver disease patients stratified by noninvasive scores. A: Non-alcoholic fatty liver disease fibrosis score; B: Fibrosis-4; C: Liver stiffness measurement; D: Albumin-bilirubin score. NFS: Non-alcoholic fatty liver disease fibrosis score; FIB-4: Fibrosis-4; LSM: Liver stiffness measurement; ALBI: Albumin-bilirubin; CKD: Chronic kidney disease.


Write to the Help Desk